291 related articles for article (PubMed ID: 19679449)
21. [Consumption of old and new antiepileptic drugs in the Czech Republic in 1999-2004].
Tlustá E; Ulmanová D; Vitásek Z; Vlcek J
Ceska Slov Farm; 2007 Jan; 56(1):37-41. PubMed ID: 17432281
[TBL] [Abstract][Full Text] [Related]
22. Initiation of treatment and selection of antiepileptic drugs in childhood epilepsy.
Oka E; Murakami N; Ogino T; Kobayashi K; Ohmori I; Akiyama T; Ito M
Epilepsia; 2004; 45 Suppl 8():17-9. PubMed ID: 15610189
[TBL] [Abstract][Full Text] [Related]
23. Current state of the union of epilepsy care in the United States: Antiepileptic drugs - An introduction to the Connectors Project.
Sirven JI; Shafer PO; Kalilani L; Wild I; Fishman J; Owens S
Epilepsy Behav; 2018 Mar; 80():98-103. PubMed ID: 29414565
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population.
Davis KL; Candrilli SD; Edin HM
Epilepsia; 2008 Mar; 49(3):446-54. PubMed ID: 18031549
[TBL] [Abstract][Full Text] [Related]
25. Association between sociodemographic status and antiepileptic drug prescriptions in children with epilepsy.
Mattsson P; Tomson T; Edebol Eeg-Olofsson K; Brännström L; Ringbäck Weitoft G
Epilepsia; 2012 Dec; 53(12):2149-55. PubMed ID: 23061699
[TBL] [Abstract][Full Text] [Related]
26. Adverse events with use of antiepileptic drugs: a prescription and event symmetry analysis.
Tsiropoulos I; Andersen M; Hallas J
Pharmacoepidemiol Drug Saf; 2009 Jun; 18(6):483-91. PubMed ID: 19326363
[TBL] [Abstract][Full Text] [Related]
27. [Evaluation of prescription practices and of the rational use of medicines in Niger].
Mallet HP; Njikam A; Scouflaire SM
Sante; 2001; 11(3):185-93. PubMed ID: 11641083
[TBL] [Abstract][Full Text] [Related]
28. Epilepsy in the elderly.
Leppik IE
Epilepsia; 2006; 47 Suppl 1():65-70. PubMed ID: 17044830
[TBL] [Abstract][Full Text] [Related]
29. Opinion of Belgian neurologists on antiepileptic drugs: Belgian Study on Epilepsy Treatment (BESET).
Legros B; Boon P; Dejonghe P; Sadzot B; Van Rijckevorsel K; Schmedding E
Acta Neurol Scand; 2007 Feb; 115(2):97-103. PubMed ID: 17212612
[TBL] [Abstract][Full Text] [Related]
30. Impact of reimbursement restrictions on the choice of antiepileptic drugs: Belgian Study on Epilepsy Treatment (BESET).
Boon P; Dejonghe P; Legros B; Sadzot B; van Rijckevorsel K; Schmedding E
Seizure; 2008 Jun; 17(4):350-7. PubMed ID: 18203628
[TBL] [Abstract][Full Text] [Related]
31. Prevalence, incidence and persistence of antipsychotic drug prescribing in the Italian general population: retrospective database analysis, 1999-2002.
Mirandola M; Andretta M; Corbari L; Sorio A; Nosè M; Barbui C
Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):412-20. PubMed ID: 16287199
[TBL] [Abstract][Full Text] [Related]
32. Prescription pattern of codeine for non-malignant pain: a pharmacoepidemiological study from the Norwegian Prescription Database.
Fredheim OM; Skurtveit S; Moroz A; Breivik H; Borchgrevink PC
Acta Anaesthesiol Scand; 2009 May; 53(5):627-33. PubMed ID: 19419357
[TBL] [Abstract][Full Text] [Related]
33. Utilisation and polypharmacy aspects of antiepileptic drugs in elderly versus younger patients with epilepsy: A pharmacoepidemiological study of CNS-active drugs in Norway, 2004-2015.
Baftiu A; Feet SA; Larsson PG; Burns ML; Henning O; Sætre E; Molden E; Granas AG; Johannessen SI; Landmark CJ
Epilepsy Res; 2018 Jan; 139():35-42. PubMed ID: 29175562
[TBL] [Abstract][Full Text] [Related]
34. Opinion of Belgian neurologists on antiepileptic drug treatment in 2006: Belgian study on epilepsy treatment (BESET-2).
Legros B; Boon P; De Jonghe P; Sadzot B; Van Rijckevorsel K; Schmedding E
Acta Neurol Scand; 2009 Dec; 120(6):402-10. PubMed ID: 19804468
[TBL] [Abstract][Full Text] [Related]
35. Increasing use of opioids from 2004 to 2007 - pharmacoepidemiological data from a complete national prescription database in Norway.
Fredheim OM; Skurtveit S; Breivik H; Borchgrevink PC
Eur J Pain; 2010 Mar; 14(3):289-94. PubMed ID: 19505834
[TBL] [Abstract][Full Text] [Related]
36. Treatment of paediatric epilepsy in Germany: antiepileptic drug utilisation in children and adolescents with a focus on new antiepileptic drugs.
Dörks M; Langner I; Timmer A; Garbe E
Epilepsy Res; 2013 Jan; 103(1):45-53. PubMed ID: 22795320
[TBL] [Abstract][Full Text] [Related]
37. Psychiatric comorbidity in patients with epilepsy: a population-based study.
Karouni M; Arulthas S; Larsson PG; Rytter E; Johannessen SI; Landmark CJ
Eur J Clin Pharmacol; 2010 Nov; 66(11):1151-60. PubMed ID: 20669014
[TBL] [Abstract][Full Text] [Related]
38. Safety aspects of antiepileptic drugs-a population-based study of adverse effects relative to changes in utilisation.
Baftiu A; Lima MH; Svendsen K; Larsson PG; Johannessen SI; Landmark CJ
Eur J Clin Pharmacol; 2019 Aug; 75(8):1153-1160. PubMed ID: 31001654
[TBL] [Abstract][Full Text] [Related]
39. Risk of aplastic anemia in patients using antiepileptic drugs.
Handoko KB; Souverein PC; van Staa TP; Meyboom RH; Leufkens HG; Egberts TC; van den Bemt PM
Epilepsia; 2006 Jul; 47(7):1232-6. PubMed ID: 16886988
[TBL] [Abstract][Full Text] [Related]
40. Clinical consequences of generic substitution of lamotrigine for patients with epilepsy.
LeLorier J; Duh MS; Paradis PE; Lefebvre P; Weiner J; Manjunath R; Sheehy O
Neurology; 2008 May; 70(22 Pt 2):2179-86. PubMed ID: 18505997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
